account
search
search

Lilly declares its final offer for SGX

  |   Aug. 4, 2008 at 2:48 PM
INDIANAPOLIS, Aug. 4 (UPI) -- Pharmaceutical giant Eli Lilly and Co. said Monday that $64 million would be its highest offer for California biotech firm SGX Pharmaceutical.

The $3 per share price was "full and fair, " Gino Santini, Eli Lilly senior vice president of corporate strategy and business development, said.

"Lilly will not increase its offer price, and we are confirming that the $3 per share price for SGX is our best and final offer," Santini said.

Lilly signed a merger agreement with cancer drug developer SGX in July, the Indianapolis Star reported.

"Lilly and SGX fully intend to take this proposal to a stockholder vote at the $3 per share offer price," Santini said.

Topics: Eli Lilly
© 2008 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
x
Feedback